EPIX Pharmaceuticals, Inc. to Present at the Thomas Weisel Partners 2007 Healthcare Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) today announced that Michael G. Kauffman, M.D., Ph.D., chief executive officer of EPIX, is scheduled to present an update on corporate activities, as well as final clinical data from the Phase 2a clinical trial of PRX-08066 in pulmonary hypertension associated with chronic obstructive pulmonary disease, at the Thomas Weisel Partners 2007 Healthcare Conference on Thursday, September 6, 2007 at 9:10 a.m. (EDT) at the Four Seasons Hotel in Boston, Massachusetts.
MORE ON THIS TOPIC